TP53 and cancer: However, one common question based on this theory is still hard to answer: why so few genes are commonly mutated in most cancers [1,132] and one obstacle occurs in cancer therapies which is still hard to solve: commonly mutated genes such as TP53 [1,41] and MYC [52,53] are hard to target.